Skip to main content
Home
Main navigation
  • About Us
  • Services
  • News & Insights
  • Careers
  • The GR Company
  • EN/한국어
  • Contact Us
  • English
  • 한국어

News & Insights

Blue House

The 22nd General Election forcasts Who will win, by how much

With just a week to go until the big day, Korea’s General Election clock is ticking.Korea’s two major parties – the People Power Party (PPP) and the Democratic Party (DP) – are accelerating their final rally to assemble the voter base. This issue pro...
Apr, 2024
Insights

Drug pricing to be more transparent: Gov’t continues systematic reform push

We at GR Korea are pleased to share important and noteworthy news in the healthcare sector of this month. We would also like to take this opportunity to thank you for your continued interest and support.Please refer to the attached document for detai...
Mar, 2024
Insights
Blue House

Parties' division, alliance, and candidate nomination

The 22nd General Election in Korea is just over a month away. Korea’s two major parties – the People Power Party (PPP) and the Democratic Party (DP) – are accelerating their candidate nomination and pledge development efforts. As of 6 March, ahead of...
Mar, 2024
Insights

Kicking off the 22nd General Election

With 50 days remaining, Korea's 22nd General Election is fast approaching.This election has the potential to significantly shift the current Korean political landscape. Accordingly, major political parties, as well as newly formed ones, have been gea...
Mar, 2024
Insights

Crisis in healthcare: Government moves to raise med school quota amid protests

Following January's newsletter, GR Korea is delighted to present important updates from the healthcare sector for this month. We also welcome your active feedback and appreciate your continued interest.Please refer to the attached document for detail...
Feb, 2024
Insights
Healthcare

The NA audit for biopharma: Key issues & what to expect

Happy new year! We are pleased to share the first 2024 edition of our healthcare newsletter. We at GR Korea have prepared this newsletter to provide our clients and partners in the healthcare sector with noteworthy developments. We hope to bring you key updates on a regular basis this year to help you stay informed about the latest developments pertaining to the biotech and pharmaceutical industries.
Jan, 2024
Insights

Pagination

  • Show more

CONTACT US

By sending, I agree to the Privacy Policy.
Footer
  • About
  • Services
  • News & Insights
  • Careers
  • Contact
Social Profile
  • LinkedIn
Sitewide
  • GR Japan
  • GR Taiwan
  • The GR Company
  • EN/JP

© 2024 GR Korea

Menu Term
  • Privacy policy